Eplerenone, sold under the brand name Inspra, is a steroidal antimineralocorticoid of the spirolactone group that is used as an adjunct in the management of chronic heart failure and high blood pressure, particularly for patients with resistant hypertension due to elevated aldosterone. Classed as a selective aldosterone receptor antagonist (SARA), it is similar to the diuretic spironolactone, though it is much more selective for the mineralocorticoid receptor in comparison (i.e., does not possess any antiandrogen, progestogen, glucocorticoid, or estrogenic effects), and is specifically marketed for reducing cardiovascular risk in patients following myocardial infarction. Eplerenone is a potassium-sparing diuretic, meaning that it helps the body get rid of water but still keep potassium. It was patented in 1983 and approved for medical use in the United States in 2002. Eplerenone is currently approved for sale in Canada, the US, EU, Netherlands and Japan.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Eplerenone industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
25 mg Tablets
50 mg Tablets
Market Segment by Product Application
Heart failure
Hypertension
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Sandoz
Apotex
Mylan
Accord Healthcare
Teva
Breckenridge Pharmaceutical
Cadila Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Eplerenone consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Eplerenone market by identifying its various subsegments.
3.Focuses on the key global Eplerenone manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Eplerenone with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Eplerenone submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Eplerenone Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Eplerenone Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Eplerenone Segment by Type
2.1.1 25 mg Tablets
2.1.2 50 mg Tablets
2.2 Market Analysis by Application
2.2.1 Heart failure
2.2.2 Hypertension
2.2.3 Others
2.3 Global Eplerenone Market Comparison by Regions (2017-2027)
2.3.1 Global Eplerenone Market Size (2017-2027)
2.3.2 North America Eplerenone Status and Prospect (2017-2027)
2.3.3 Europe Eplerenone Status and Prospect (2017-2027)
2.3.4 China Eplerenone Status and Prospect (2017-2027)
2.3.5 Japan Eplerenone Status and Prospect (2017-2027)
2.3.6 Southeast Asia Eplerenone Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Eplerenone Industry Impact
2.5.1 Eplerenone Business Impact Assessment - Covid-19
2.5.2 Market Trends and Eplerenone Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Eplerenone Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Eplerenone Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Eplerenone Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Eplerenone Manufacturer Market Share
3.5 Top 10 Eplerenone Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Eplerenone Market
3.7 Key Manufacturers Eplerenone Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Eplerenone Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Eplerenone Product Introduction, Application and Specification
4.1.3 Pfizer 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Sandoz
4.2.1 Compan Detail
4.2.2 Sandoz Eplerenone Product Introduction, Application and Specification
4.2.3 Sandoz Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Apotex
4.3.1 Compan Detail
4.3.2 Apotex Eplerenone Product Introduction, Application and Specification
4.3.3 Apotex Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Apotex News
4.4 Mylan
4.4.1 Compan Detail
4.4.2 Mylan Eplerenone Product Introduction, Application and Specification
4.4.3 Mylan Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Mylan News
4.5 Accord Healthcare
4.5.1 Compan Detail
4.5.2 Mylan Eplerenone Product Introduction, Application and Specification
4.5.3 Accord Healthcare Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Accord Healthcare News
4.6 Teva
4.6.1 Compan Detail
4.6.2 Teva Eplerenone Product Introduction, Application and Specification
4.6.3 Teva Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Teva News
4.7 Breckenridge Pharmaceutical
4.7.1 Compan Detail
4.7.2 Breckenridge Pharmaceutical Eplerenone Product Introduction, Application and Specification
4.7.3 Breckenridge Pharmaceutical Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Cadila Pharmaceuticals
4.8.1 Compan Detail
4.8.2 Cadila Pharmaceuticals Eplerenone Product Introduction, Application and Specification
4.8.3 Cadila Pharmaceuticals Eplerenone Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Cadila Pharmaceuticals News
5 Global Eplerenone Market Segment by Big Type
5.1 Global Eplerenone Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Eplerenone Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Eplerenone Revenue and Market Share by Big Type (2017-2022)
5.2 25 mg Tablets Sales Growth Rate and Price
5.2.1 Global 25 mg Tablets Sales Growth Rate (2017-2022)
5.2.2 Global 25 mg Tablets Price (2017-2022)
5.3 50 mg Tablets Sales Growth Rate and Price
5.3.1 Global 50 mg Tablets Sales Growth Rate (2017-2022)
5.3.2 Global 50 mg Tablets Price (2017-2022)
6 Global Eplerenone Market Segment by Big Application
6.1 Global Eplerenone Sales Market Share by Big Application (2017-2022)
6.2 Heart failure Sales Growth Rate (2017-2022)
6.3 Hypertension Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Eplerenone Forecast
7.1 Global Eplerenone Revenue, Sales and Growth Rate (2022-2027)
7.2 Eplerenone Market Forecast by Regions (2022-2027)
7.2.1 North America Eplerenone Market Forecast (2022-2027)
7.2.2 Europe Eplerenone Market Forecast (2022-2027)
7.2.3 China Eplerenone Market Forecast (2022-2027)
7.2.4 Japan Eplerenone Market Forecast (2022-2027)
7.2.5 Southeast Asia Eplerenone Market Forecast (2022-2027)
7.2.6 Other Regions Eplerenone Market Forecast (2022-2027)
7.3 Eplerenone Market Forecast by Type (2022-2027)
7.3.1 Global Eplerenone Sales Forecast by Type (2022-2027)
7.3.2 Global Eplerenone Market Share Forecast by Type (2022-2027)
7.4 Eplerenone Market Forecast by Application (2022-2027)
7.4.1 Global Eplerenone Sales Forecast by Application (2022-2027)
7.4.2 Global Eplerenone Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Eplerenone Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Eplerenone Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Eplerenone
Figure Market Concentration Ratio and Market Maturity Analysis of Eplerenone
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Eplerenone Market Size by Big Type
Figure Global Market Share of Eplerenone by Big Type in 2021
Figure 25 mg Tablets Picture (2017-2022)
Global Eplerenone Market Size by Big Application
Table Global Eplerenone Market Size by Application
Figure Global Eplerenone Market Share by Big Application in 2021
Figure Heart failure Picture
Figure Hypertension Picture
Figure Others Picture
Table Global Eplerenone Comparison by Regions (M USD) (2017-2027)
Figure Global Eplerenone Market Size (Million US$) (2017-2027)
Figure North America Eplerenone Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Eplerenone Revenue (Million US$) Growth Rate (2017-2027)
Figure China Eplerenone Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Eplerenone Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Eplerenone Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Eplerenone Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Eplerenone Sales by Manufacturer (2017-2022)
Figure Global Eplerenone Sales Market Share by Manufacturer in 2021
Table Global Eplerenone Revenue by Manufacturer (2017-2022)
Figure Global Eplerenone Revenue Market Share by Manufacturer in 2021
Table Global Eplerenone Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Eplerenone Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Eplerenone Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Eplerenone Market
Table Key Manufacturers Eplerenone Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Eplerenone Product Introduction, Application and Specification of Pfizer
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Sandoz Company Profile
Table Eplerenone Product Introduction, Application and Specification of Sandoz
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sandoz Recent Development
Table Apotex Company Profile
Table Eplerenone Product Introduction, Application and Specification of Apotex
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Apotex Main Business
Table Apotex Recent Development
Table Mylan Company Profile
Table Eplerenone Product Introduction, Application and Specification of Mylan
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Mylan Main Business
Table Mylan Recent Development
Table Accord Healthcare Company Profile
Table Eplerenone Product Introduction, Application and Specification of Accord Healthcare
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Accord Healthcare Main Business
Table Accord Healthcare Recent Development
Table Teva Company Profile
Table Eplerenone Product Introduction, Application and Specification of Teva
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table Breckenridge Pharmaceutical Company Profile
Table Eplerenone Product Introduction, Application and Specification of Breckenridge Pharmaceutical
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Breckenridge Pharmaceutical Main Business
Table Breckenridge Pharmaceutical Recent Development
Table Cadila Pharmaceuticals Company Profile
Table Eplerenone Product Introduction, Application and Specification of Cadila Pharmaceuticals
Table Eplerenone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cadila Pharmaceuticals Main Business
Table Cadila Pharmaceuticals Recent Development
Figure Global Eplerenone Sales and Growth Rate (2017-2022)
Figure Global Eplerenone Revenue and Growth Rate (2017-2022)
Table Global Eplerenone Sales by Regions (2017-2022)
Figure Global Eplerenone Sales Market Share by Regions in 2021
Table Global Eplerenone Revenue by Regions (2017-2022)
Figure Global Eplerenone Revenue Market Share by Regions in 2021
Figure North America Eplerenone Sales and Growth Rate (2017-2022)
Figure Europe Eplerenone Sales and Growth Rate (2017-2022)
Figure China Eplerenone Sales and Growth Rate (2017-2022)
Figure Japan Eplerenone Sales and Growth Rate (2017-2022)
Figure Southeast Asia Eplerenone Sales and Growth Rate (2017-2022)
Figure Other Regions Eplerenone Sales and Growth Rate (2017-2022)
Table Global Eplerenone Sales by Big Type (2017-2022)
Table Global Eplerenone Sales Market Share by Big Type (2017-2022)
Figure Global Eplerenone Sales Market Share by Big Type in 2019
Table Global Eplerenone Revenue by Big Type (2017-2022)
Table Global Eplerenone Revenue Market Share by Big Type (2017-2022)
Table Global Eplerenone Revenue Market Share by Big Type in 2019
Figure Global 25 mg Tablets Sales Growth Rate (2017-2022)
Figure Global 25 mg Tablets Price (2017-2022)
Figure Global 50 mg Tablets Sales Growth Rate (2017-2022)
Table Global Eplerenone Sales by Big Application (2017-2022)
Table Global Eplerenone Sales Market Share by Big Application (2017-2022)
Figure Global Eplerenone Sales Market Share by Big Application in 2019
Figure Global Heart failure Sales Growth Rate (2017-2022)
Figure Global Hypertension Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Eplerenone Sales and Growth Rate (2022-2027)
Figure Global Eplerenone Revenue and Growth Rate (2022-2027)
Table Global Eplerenone Sales Forecast by Regions (2022-2027)
Table Global Eplerenone Market Share Forecast by Regions (2022-2027)
Figure North America Sales Eplerenone Market Forecast (2022-2027)
Figure Europe Sales Eplerenone Market Forecast (2022-2027)
Figure China Sales Eplerenone Market Forecast (2022-2027)
Figure Japan Sales Eplerenone Market Forecast (2022-2027)
Figure Southeast Asia Sales Eplerenone Market Forecast (2022-2027)
Figure Other Regions Sales Eplerenone Market Forecast (2022-2027)
Table Global Eplerenone Sales Forecast by Type (2022-2027)
Table Global Eplerenone Market Share Forecast by Type (2022-2027)
Table Global Eplerenone Sales Forecast by Application (2022-2027)
Table Global Eplerenone Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Eplerenone
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Eplerenone Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Eplerenone Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Eplerenone Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Eplerenone Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Eplerenone Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Eplerenone Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Eplerenone Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Eplerenone Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Sandoz
Apotex
Mylan
Accord Healthcare
Teva